Download presentation
Presentation is loading. Please wait.
1
Respiratory Failure (RF)
Prof. Omer Alamoudi, MD, FRCP, FCCP,FACP
2
Respiratory Failure (RF)
Normal ABG Definition Classification of RF Distinction between Acute and Chronic RF Pathophysiologic causes of Acute RF Diagnosis of RF Causes Clinical presentation Investigations Management of RF
3
Arterial Blood Gases (ABG) Normal values at sea level
pH PaO2 >70 mmHg PaCO mmHg HCO mmol/l Minute ventilation = Tidal volume X Respiratory rate ↓pH Acidosis ↑pH Alkalosis ↓ PaO2 Hypoxemia ↑PaCO2 Hypercapnia ↓pH+ ↑PaCO2 R. acidosis ↑HCO3 ↑pH+↓PaCO2 R.Alkalosis ↓HCO3
4
Respiratory Failure (RF)
Definitions Clinical conditions in which PaO2 < 60 mmHg while breathing room air or a PaCO2 > 50 mmHg Failure of oxygenation and carbon dioxide elimination Acute and chronic Type 1 or 2
5
Classification of RF Type 1 Type 2 Hypoxemic RF **
PaO2 < 60 mmHg with normal or ↓ PaCO2 Associated with acute diseases of the lung Pulmonary edema (Cardiogenic, noncardiogenic (ARDS), pneumonia, pulmonary hemorrhage, and collapse Type 2 Hypercapnic RF PaCO2 > 50 mmHg Hypoxemia is common Drug overdose, neuromuscular disease, chest wall deformity, COPD, and Bronchial asthma
6
Distinction between Acute and Chronic RF
Acute RF Develops over minutes to hours ↓ pH quickly to <7.2 Example; Pneumonia Chronic RF Develops over days ↑ in HCO3 ↓ pH slightly Polycythemia, Corpulmonale Example; COPD
7
Pathophysiologic causes of Acute RF
●Hypoventilation ●V/P mismatch ●Shunt ●Diffusion abnormality
8
Pathophysiologic causes of Acute RF 1 - Hypoventilation
Occurs when ventilation ↓ 4-6 l/min Causes Depression of CNS from drugs Neuromuscular disease of respiratory ms ↑PaCO2 and ↓PaO2 Alveolar –arterial PO2 gradient is normal COPD
9
Pathophysiologic causes of Acute RF
●Hypoventilation ●V/P mismatch ●Shunt ●Diffusion abnormality 9
10
Pathophysiologic causes of Acute RF 2 -V/Q mismatch
Most common cause of hypoxemia Low V/Q ratio, may occur either from Decrease of ventilation 2ry to airway or interstitial lung disease Overperfusion in the presence of normal ventilation e.g. PE Admin. of 100% O2 eliminate hypoxemia
11
Pathophysiologic causes of Acute RF
●Hypoventilation ●V/P mismatch ●Shunt ●Diffusion abnormality 11
12
Pathophysiologic causes of Acute RF 3 -Shunt
The deoxygenated blood bypasses the ventilated alveoli and mixes with oxygenated blood → hypoxemia Persistent of hypoxemia despite 100% O2 inhalation Hypercapnia occur when shunt is excessive > 60%
13
Pathophysiologic causes of Acute RF 3 – Causes of Shunt
Intracardiac Right to left shunt Fallot’s tetralogy Eisenmenger’s syndrome Pulmonary A/V malformation Pneumonia Pulmonary edema Atelectasis/collapse Pulmonary Hge Pulmonary contusion
14
Pathophysiologic causes of Acute RF
●Hypoventilation ●V/P mismatch ●Shunt ●Diffusion abnormality 14
15
Pathophysiologic causes of Acute RF 4 - Diffusion abnormality
Less common Due to abnormality of the alveolar membrane ↓ the number of the alveoli Causes ARDS Fibrotic lung disease
16
Diagnosis of RF 1 – Clinical (symptoms, signs)
Hypoxemia Dyspnea, Cyanosis Confusion, somnolence, fits Tachycardia, arrhythmia Tachypnea (good sign) Use of accessory ms Nasal flaring Recession of intercostal ms Polycythemia Pulmonary HTN, Corpulmonale, Rt. HF Hypercapnia ↑Cerebral blood flow, and CSF Pressure Headache Asterixis Papilloedema Warm extremities, collapsing pulse Acidosis (respiratory, and metabolic) ↓pH, ↑ lactic acid
17
Diagnosis of RF 2 – Causes
1 – CNS Depression of the neural drive to breath Brain stem tumors or vascular abnormality Overdose of a narcotic, sedative Myxedema, chronic metabolic alkalosis Acute or chronic hypoventilation and hypercapnia
18
Diagnosis of RF 2 – Causes
2 - Disorders of peripheral nervous system, Respiratory ms, and Chest wall Inability to maintain a level of minute ventilation appropriate for the rate of CO2 production Guillian-Barre syndrome, muscular dystrophy, myasthenia gravis, KS, morbid obesity Hypoxemia and hypercapnia
19
Diagnosis of RF 2 – Causes
3 - Abnormities of the airways Upper airways Acute epiglotitis Tracheal tumors Lower airway COPD, Asthma, cystic fibrosis Acute and chronic hypercapnia
20
Diagnosis of RF 2 – Causes
4 - Abnormities of the alveoli Diffuse alveolar filling hypoxemic RF Cardiogenic and noncardiogenic pulmonary edema Aspiration pneumonia Pulmonary hemorrhage Associate with Intrapulmonary shunt and increase work of breathing
21
Diagnosis of RF 3 – Common causes
Hypercapnic RF Hypoxemic RF Chronic bronchitis,emphysema Severe asthma, drug overdose Poisonings, Myasthenia gravis Polyneuropathy, Poliomyelitis Primary ms disorders 1ry alveolar hypoventilation Obesity hypoventilation synd. Pulmonary edema, ARDS Myxedema, head and cervical cord injury Chronic bronchitis, emphysema Pneumonia, pulmonary edema Pulmonary fibrosis Asthma, pneumothorax Pulmonary embolism, Pulmonary hypertension Bronchiectasis, ARDS Fat embolism, KS, Obesity Cyanotic congenital heart disease Granulomatous lung disease
22
Diagnosis of RF 3 - Investigations
ABG CBC, Hb Anemia → tissue hypoxemia Polycythemia → chronic RF Urea, Creatinine LFT → clues to RF or its complications Electrolytes (K, Mg, Ph) → Aggravate RF ↑ CPK, ↑ Troponin 1 → MI ↑CPK, normal Troponin 1 → Myositis TSH → Hypothyroidism
23
Diagnosis of RF 3 - Investigations
Chest x ray → Pulmonary edema → ARDS Echocardiography → Cardiogenic pulmonary edema → ARDS → PAP, Rt ventricular hypertrophy in CRF ■ PFT- (FEV1/ FVC ratio) Decrease → Airflow obstruction Increase → Restrictive lung disease
24
Diagnosis of RF 3 - Investigations
ECG → cardiac cause of RF → Arrhythmia due to hypoxemia and severe acidosis ■ Right heart catheterization to measure ●Pulmonary capillary wedge pressure (PCWP) ● Normal → ARDS (<18 mmHg) ● Increased → Cardiogenic pulmonary edema
25
Distinction between Noncardiogenic (ARDS) and Cardiogenic pulmonary edema
26
Distinction between Noncardiogenic (ARDS) and Cardiogenic pulmonary edema
Tachypnea, dyspnea, crackles Aspiration, sepsis 3 to 4 quadrant of alveolar flooding with normal heart size, systolic, diastolic function Decreased compliance Severe hypoxemia refractory to O2 therapy PCWP is normal <18 mm Hg Cardiogenic edema Tachypnea, dyspnea, crackles Lt ventricular dysfunction, valvular disease, IHD Cardiomegaly, vascular redistribution, pleural effusion, perihilar bat-wing distribution of infiltrate Hypoxemia improved on high flow O2 PCWP is High >18 mmHg
27
Management of ARF
28
Management of ARF ICU admition 1 -Airway management Indications
Endotracheal intubation: Indications Severe Hypoxemia Altered mental status Importance precise O2 delivery to the lungs remove secretion ensures adequate ventilation
29
Management of ARF 2 -Correction of hypoxemia
O2 administration via nasal prongs, face mask, intubation and Mechanical ventilation Goal: Adequate O2 delivery to tissues PaO2 = > 60 mmHg Arterial O2 saturation >90%
30
Management of ARF 3- Correction of hypercapnia
Control the underlying cause Controlled O2 supply 1 -3 lit/min, titrate according O2 saturation O2 supply to keep the O2 saturation >90% but <93 to avoid inducing hypercapnia COPD-chronic bronchitis, emphysema 30
31
Management of ARF Oxyhemoglobin dissociations curve 60mmHg 31
32
Management of ARF 4 – Mechanical ventilation Indications
Persistence hypoxemia despite O2supply Decreased level of consciousness Hypercapnia with severe acidosis (pH< 7.2)
33
Management of ARF 4 - Mechanical ventilation Increase PaO2 Lower PaCO2
Rest respiratory ms (respiratory ms fatigue) Ventilator Assists or controls the patient breathing The lowest FIO2 that produces SaO2 >90% and PO2 >60 mmHg should be given to avoid O2 toxicity
34
Management of ARF 5 -PEEP (positive End-Expiratory pressure
Used with mechanical ventilation Increase intrathoracic pressure Keeps the alveoli open Decrease shunting Improve gas exchange Hypoxemic RF (type 1) ARDS Pneumonias
35
Management of ARF 6 - Noninvasive Ventilatory support (IPPV)
Mild to moderate RF Patient should have Intact airway, Alert, normal airway protective reflexes Nasal or full face mask Improve oxygenation, Reduce work of breathing Increase cardiac output AECOPD, asthma, CHF
36
Management of ARF 7 - Treatment of the underlying causes
After correction of hypoxemia, hemodynamic stability Antibiotics Pneumonia Infection Bronchodilators (COPD, BA) Salbutamol reduce bronchospasm airway resistance 36
37
Management of ARF 7 - Treatment of the underlying causes
Anticholinergics (COPD,BA) Ibratropium bromide inhibit vagal tone relax smooth ms Theophylline (COPD, BA) improve diaphragmatic contraction Diuretics (pulmonary edema) Frusemide, Metalzone
38
Management of ARF 7 - Treatment of the underlying causes
Methyl prednisone (COPD, BA, acute esinophilic pn) Reverse bronchospasm, inflammation Fluids and electrolytes Maintain fluid balance and avoid fluid overload IV nutritional support To restore strength, loss of ms mass Fat, carbohydrate, protein
39
Management of ARF 7 - Treatment of the underlying causes Physiotherapy
Chest percussion to loosen secretion Suction of airways Help to drain secretion Maintain alveolar inflation Prevent atelectasis, help lung expansion
40
Management of ARF 8 - Weaning from mechanical ventilation
Stable underlying respiratory status Adequate oxygenation Intact respiratory drive Stable cardiovascular status Patient is a wake, has good nutrition, able to cough and breath deeply
41
Complications of ARF GIT Pulmonary Pulmonary embolism barotrauma
pulmonary fibrosis (ARDS) Nosocomial pneumonia Cardiovascular Hypotension, ↓COP Arrhythmia MI, pericarditis GIT Stress ulcer, ileus, diarrhea, hemorrhage Infections Nosocomial infection Pneumonia, UTI, catheter related sepsis Renal ARF (hypoperfusion, nephrotoxic drugs) Poor prognosis Nutritional Malnutrition, diarrhea hypoglycemia, electrolyte disturbances
42
Prognosis of ARF Mortality rate for ARDS → 40%
Younger patient <60 has better survival rate 75% of patient survive ARDS have impairment of pulmonary function one or more years after recovery Mortality rate for COPD →10% Mortality rate increase in the presence of hepatic, cardiovascular, renal, and neurological disease
43
Quiz
44
Thank you
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.